Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 10701, November 15, 2006. doi: 10.1158/0008-5472.CAN-06-0999
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, P.-Y.
Right arrow Articles by Berger, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, P.-Y.
Right arrow Articles by Berger, S. L.

Molecular Biology, Pathobiology, and Genetics

LKB1 Is Recruited to the p21/WAF1 Promoter by p53 to Mediate Transcriptional Activation

Ping-Yao Zeng1,2 and Shelley L. Berger1

1 Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania and 2 Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan Province, P.R. China

Requests for reprints: Shelley L. Berger, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. Phone: 215-898-3922; Fax: 215-898-0663; E-mail: berger{at}wistar.upenn.edu.

The tumor suppressor LKB1 is an evolutionarily conserved serine/threonine kinase. In humans, LKB1 can be inactivated either by germ-line mutations resulting in Peutz-Jeghers syndrome or by somatic mutations causing predisposition to multiple sporadic cancers. LKB1 has wide-ranging functions involved in tumor suppression and cell homeostasis, including establishing cell polarity, setting energy metabolic balance (via phosphorylation of AMP-dependent kinase), regulating the cell cycle, and promoting apoptosis. LKB1 function was previously linked to the tumor suppressor p53 and shown to activate the p53 target gene p21/WAF1. In this study, we further investigated LKB1 activation of the p21/WAF1 gene and addressed whether LKB1 is directly involved at the gene promoter. We find that, consistent with previous studies, LKB1 stabilizes p53 in vivo, correlating with activation of p21/WAF1. We show that LKB1 physically associates with p53 in the nucleus and directly or indirectly phosphorylates p53 Ser15 (previously shown to be phosphorylated by AMP-dependent kinase) and p53 Ser392. Further, these two p53 residues are required for LKB1-dependent cell cycle G1 arrest. Chromatin immunoprecipitation analyses show that LKB1 is recruited directly to the p21/WAF1 promoter, as well as to other p53 activated promoters, in a p53-dependent fashion. Finally, a genetic fusion of LKB1 to defective p53, deleted for its activation domains, promotes activation of p21/WAF1. These results indicate that LKB1 has a direct role in activation of p21/WAF1 gene. (Cancer Res 2006; 66(22): 10701-8)




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
D. Fan, C. Ma, and H. Zhang
The molecular mechanisms that underlie the tumor suppressor function of LKB1
Acta Biochim Biophys Sin, February 1, 2009; 41(2): 97 - 107.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Zhong, X. Liu, F. R. Khuri, S.-Y. Sun, P. M. Vertino, and W. Zhou
LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic Proteins
Cancer Res., September 15, 2008; 68(18): 7270 - 7277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Dorfman and I. G. Macara
STRAD{alpha} Regulates LKB1 Localization by Blocking Access to Importin-{alpha}, and by Association with Crm1 and Exportin-7
Mol. Biol. Cell, April 1, 2008; 19(4): 1614 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Scott, S. Nath-Sain, M. D. Agnew, and P. A. Marignani
LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression
Cancer Res., June 15, 2007; 67(12): 5622 - 5627.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.